The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Hemoccult Screening in Detecting Colorectal Neoplasm: Sensitivity, Specificity, and Predictive Value: Long-Term Follow-up in a Large Group Practice Setting

James E. Allison, MD; Robert Feldman, MD; and Irene S. Tekawa, MA
[+] Article, Author, and Disclosure Information

Grant Support: By the Community Service Program of Kaiser Foundation Hospitals.

Requests for Reprints: James E. Allison, MD, Department of Medicine, Kaiser Permanente Medical Center, 280 W. MacArthur Boulevard, Oakland, CA 94611-5463.

Current Author Addresses: Dr. Allison: Department of Medicine, Kaiser Permanente Medical Center, 280 W. MacArthur Boulevard, Oakland, CA 94611-5463.

Dr. Feldman: 36 Northgate Avenue, Berkeley, CA 94708.

Ms. Tekawa: Kaiser Permanente Medical Care Program, Division of Research, 3451 Piedmont Avenue, Oakland, CA 94611-5463.

Ann Intern Med. 1990;112(5):328-333. doi:10.7326/0003-4819-112-5-328
Text Size: A A A

Study Objective: To determine the sensitivity, specificity, and predictive value of Hemoccult II tests for detecting colorectal neoplasm (colorectal carcinoma or polyp or both).

Study Design: Prospective analyses of asymptomatic patients ( ≥ 45 years) followed for 4 years after screening with Hemoccult II testing and retrospective analyses of patients with known colorectal carcinoma or polyps or both who had Hemoccult II testing within 2 years of diagnosis.

Setting: A large, health maintenance organization practice.

Measurements and Main Results: In the prospective analysis, the sensitivity of Hemoccult II was 50% for colorectal carcinoma diagnosed within 1 year of testing, 43% within 2 years, and 25% within 4 years. For polyps, sensitivity was 36% at 1 year, 28% at 2 years, and 17% at 4 years. Specificity was 99%. The predictive value of a positive test for colorectal carcinoma was 8% at 1 year, 10% at 2 years, and 11 % at 4 years. On the basis of the retrospective analyses, the sensitivity of Hemoccult II for colorectal carcinoma diagnosed within 1 year of testing was 66% and was 61% within 2 years. Many of these patients had symptoms when tested.

Conclusions: An asymptomatic patient age 45 or older with a positive Hemoccult II test has about a chance of 1 in 10 for having colorectal carcinoma and a 1-in-3 chance of having either a colorectal carcinoma or polyp: The same patient with a negative Hemoccult test has a 0.2% chance of having a colorectal carcinoma diagnosed within 2 years of testing and a 0.7% chance of having a polyp. Within 4 years of testing the chance increases to 0.5% for colorectal carcinoma and 1.5% for polyps. If Hemoccult II slides are the only screening method used for detecting asymptomatic colorectal neoplasms, 50% to 60% of lesions will remain undetected. Clinical interpretation of Hemoccult screening requires appreciation of its limits as well as its benefits.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Topic Collections
PubMed Articles
Mortality in people with intellectual disabilities in England. J Intellect Disabil Res Published online Aug 2, 2016;
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.